Status:
UNKNOWN
Exploring Worry in CFS/ME
Lead Sponsor:
King's College London
Collaborating Sponsors:
South London and Maudsley NHS Foundation Trust
Conditions:
Chronic Fatigue Syndrome
Eligibility:
All Genders
18-99 years
Brief Summary
This study will be building on the findings of Kalfas et al 2022 paper exploring the prevalence of generalised worry in patients with Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) befor...
Detailed Description
A recent study carried out in SLaM explored how common worry is in people who have received Cognitive Behavioural Therapy (CBT) for CFS/ME. Over 70% were struggling with worry, and the more severe the...
Eligibility Criteria
Inclusion
- have a diagnosis of ME/CFS according to NICE criteria;
- have agreed to CBT for ME/CFS following their initial assessment;
- are/were struggling with comorbid generalised worry as determined by a score of 45 or above on the Penn State Worry Questionnaire (collected routinely with all patients referred to the service).
- Informed consent to taking part in the study
Exclusion
- Patients who have been closed to the service longer than 3 months
- Patients with a diagnosis of long-Covid
- Patients who are under 18
- Patients who do not have a diagnosis of CFS/ME
- Patients who have not agreed to CBT for CFS/ME as part of their treatment
- Patients who score below the threshold on the PSWQ
Key Trial Info
Start Date :
October 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2024
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06011135
Start Date
October 1 2023
End Date
May 31 2024
Last Update
August 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kings College London
London, United Kingdom